Table 1.

Demographics and activity by dose for active participants^a in v-safe, December 14, 2020 – December 13, 2021.

Characteristic	Pfizer-BioNTechb N = 4694527		Modernab N = 4184910		Janssenb N = 462071		Unknownb N = 1074		Total N = 9342582		COVID-19 vaccinated U.S. population in study periodc
	n	%	n	%	n	%	n	%	n	%	%
Sex
Female	2,915,900	62.11	2,639,234	63.07	267,390	57.87	543	50.56	5,823,067	62.33	51.84
Male	1,735,902	36.98	1,503,489	35.93	192,444	41.65	515	47.95	3,432,350	36.74	47.28
Other	5,927	0.13	4,432	0.11	780	0.17	3	0.28	11,142	0.12	0.87
Prefer not to say	36,798	0.78	37,755	0.90	1,457	0.32	13	1.21	76,023	0.81	n/a
Age Group (years)d
0–4	3e	0.00	0	---	0	---	0	---	3	0.00	0.01
5–11	51,621	1.10	24e	0.00	11e	0.00	61	5.68	51,717	0.55	2.53
12–17	187,101	3.99	1,435e	0.03	428e	0.09	116	10.80	189,080	2.02	6.67
18–49	2,307,945	49.16	1,908,767	45.61	265,887	57.54	593	55.21	4,483,192	47.99	44.15
50–64	1,265,662	26.96	1,185,640	28.33	156,877	33.95	175	16.29	2,608,354	27.92	23.65
65–74	655,223	13.96	805,837	19.26	32,753	7.09	96	8.94	1,493,909	15.99	13.68
≥75	226,972	4.83	283,207	6.77	6,115	1.32	33	3.07	516,327	5.53	9.31
Race and Ethnicity
Hispanic or Latino	535,530	11.41	431,254	10.30	59,199	12.81	193	17.97	1,026,176	10.98	15.02
Non-Hispanic or Latino
American Indian or Alaska Native	15,742	0.34	17618	0.42	1576	0.34	9	0.84	34945	0.37	0.68
Asian	360,630	7.68	243675	5.82	31999	6.93	130	12.10	636434	6.81	4.94
Black	298,579	6.36	239407	5.72	31228	6.76	159	14.80	569373	6.09	7.48
Native Hawaiian or Pacific Islander	13,285	0.28	10910	0.26	1325	0.29	8	0.74	25528	0.27	0.23
White	2,817,982	60.03	2602554	62.19	298887	64.68	333	31.01	5719756	61.22	42.37
Multi-racial	79,777	1.70	56831	1.36	8237	1.78	21	1.96	144866	1.55	1.68
Other	30,673	0.65	22715	0.54	3140	0.68	12	1.12	56540	0.61	2.98
Race unknown or not reported	16,005	0.34	13489	0.32	1567	0.34	5	0.47	31066	0.33	n/a
Unknown ethnicity
American Indian or Alaska Native	1,808	0.04	2162	0.05	188	0.04	5	0.47	4163	0.04	n/a
Asian	27,013	0.58	20153	0.48	2967	0.58	21	1.96	49884	0.53	n/a
Black	17,642	0.38	16334	0.39	2151	0.47	39	3.63	36166	0.39	n/a
Native Hawaiian or Pacific Islander	1,399	0.03	1183	0.03	155	0.03	3	0.28	2740	0.03	n/a
White	70,103	1.49	71646	1.71	7824	1.69	34	3.17	149607	1.60	n/a
Multi-racial	4,901	0.10	3514	0.08	538	0.12	7	0.65	8960	0.10	n/a
Other	9,589	0.20	7983	0.19	1151	0.25	11	1.02	18734	0.20	n/a
Race unknown or not reported	88,329	1.88	77569	1.85	10055	2.18	83	7.73	176036	1.88	n/a
Missing	305,540	6.51	345913	8.27	154	0.03	1	0.09	651608	6.97	24.61
Participants completing at least one survey by Dec. 13, 2021
Dose 1	3,975,829	84.7	3,697,178	88.3	452,483	97.9	522	48.6	8,126,012	87.0	n/a
Dose 2	3,545,310	75.5	3,134,156	74.9	59,909	13.0	323	30.1	6,739,698	72.1	n/a
Dose 3	590,323	12.6	517,312	12.4	780	0.2	288	26.8	1,108,703	11.9	n/a

^aActive participants completed at least one health survey in v-safe, after one or more doses of COVID-19 vaccines.

^bManufacturer of first dose of vaccine reported to v-safe by participant; some participants reported a different vaccine manufacturer for subsequent doses.

^cIncludes persons receiving at least one dose of COVID-19 vaccine in U.S. states and territories from December 14, 2020 – December 13, 2021; source: Centers for Disease Control and Prevention. COVID Data Tracker.

^dAge at first recorded dose in v-safe.

^eFirst recorded dose manufacturer, unknown whether entries were in error or represent unauthorized use of vaccines.